Skip to content

study of temporal asymmetric visual stimulation in the treatment of amblyopia in adults

A prospective clinical study of temporal asymmetric visual stimulation in the treatment of amblyopia in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108814
Enrollment
Unknown
Registered
2025-09-05
Start date
2025-09-05
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The vision of the amblyopic eye is below 0.8, with decreased contrast sensitivity and impaired stereoscopic vision

Interventions

controll group:Time synchronized visual stimulation
Test group:temporal asymmetric visual stimulation

Sponsors

China Rehabilitation Research Center(Beijing Bo'ai Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18 and above, with no gender restrictions; 2.Diagnosed as amblyopia patient through outpatient service; 3.The difference in dioptric power between the two eyes in terms of spherical lenses is greater than 1.50 DS, or the difference in dioptric power in terms of cylindrical lenses is greater than 1.00 DC; 4.Binocular visual acuity difference > 0.2 (> 0.2 logMAR); 5.The vision has been corrected by optical corrective glasses for at least two months; 6.Clinical examination did not reveal any organic lesions in both eyes; 7.do not undergone any simple occlusion or other amblyopia training in the past month;

Exclusion criteria

Exclusion criteria: 1.Clinical examination reveals organic lesions; 2.Participants have received simple occlusion or other amblyopia training within the past month; 3.Participants with any acute or chronic diseases or genetic visual system disorders; 4.The participant has a history of strabismus in the past; 5.Known allergy to mydriatic drugs such as atropine; 6.Known history of eye surgery; 7.Other situations that researchers believe are not suitable for participating in clinical trials;

Design outcomes

Primary

MeasureTime frame
LogMAR corrected vision and EDTRS corrected vision;

Secondary

MeasureTime frame
stereopsis;contrast sensitivity;

Countries

China

Contacts

Public ContactJie Zhou

China Rehabilitation Research Center(Beijing Bo'ai Hospital)

ashily.hi@163.com+86 10 87569232

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026